Vital Innovations Holdings Full Year 2024 Earnings: CN¥0.025 loss per share (vs CN¥0.025 loss in FY 2023)

Vital Innovations Holdings (HKG:6133) Full Year 2024 Results

Key Financial Results

• Revenue: CN¥1.06b (up 27% from FY 2023).
• Net loss: CN¥21.0m (flat on FY 2023).
• CN¥0.025 loss per share (in line with FY 2023).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Vital Innovations Holdings shares are down 3.4% from a week ago.

Risk Analysis

Before we wrap up, we've discovered 1 warning sign for Vital Innovations Holdings that you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.